Insights

Oncology Leadership Leverage existing alliance with the Alliance for Clinical Trials in Oncology to position LabCorp Covance as the go-to full-service oncology development partner for biopharma sponsors, offering end-to-end trial design, site operations, patient recruitment, and integrated data management.

Digital Trial Enablement Capitalize on ColoSense at-home RNA screening and the MyLabcorp AI app to offer decentralized trial solutions, remote screening, digital consent, and ongoing health monitoring that can improve patient recruitment and retention for sponsors.

Global Site Expansion Utilize Bangalore and broader Asia expansion to position LabCorp Covance as a cost-efficient, globally scalable trial operations partner for sponsors expanding in Asia, offering local investigator networks, regulatory support, and faster site onboarding.

Data Integration Advantage Promote integrated data and analytics capabilities built on LabCorp's tech stack to deliver unified trial datasets, real world evidence, and outcomes dashboards that help sponsors accelerate decision making and regulatory submissions.

Security and Compliance Highlight robust PHI protection and compliance practices to reassure sponsors after data breach incidents, and offer comprehensive cybersecurity, data governance, and security services as a differentiator in clinical trials.

LabCorp Clinical Trials Tech Stack

LabCorp Clinical Trials uses 8 technology products and services including Micro Focus Application Lifecycle Management, Adobe, Saba LMS, and more. Explore LabCorp Clinical Trials's tech stack below.

  • Micro Focus Application Lifecycle Management
    Application Development & Management
  • Adobe
    Audio, Video, Graphics
  • Saba LMS
    Corporate Learning Management Systems
  • The Prosci ADKAR Model
    Corporate Performance Management
  • SAP Plant Maintenance
    Enterprise Resource Planning
  • OpenAI Codex
    Machine Learning
  • Oracle Eloqua
    Marketing Automation
  • FedEx
    Transportation And Fleet Management

Media & News

LabCorp Clinical Trials's Email Address Formats

LabCorp Clinical Trials uses at least 1 format(s):
LabCorp Clinical Trials Email FormatsExamplePercentage
First.Last@labcorp.comJohn.Doe@labcorp.com
74%
LastF@labcorp.comDoeJ@labcorp.com
21%
First_Last@labcorp.comJohn_Doe@labcorp.com
3%
Last.First@labcorp.comDoe.John@labcorp.com
2%

Frequently Asked Questions

What is LabCorp Clinical Trials's official website and social media links?

Minus sign iconPlus sign icon
LabCorp Clinical Trials's official website is labcorp.com and has social profiles on LinkedIn.

What is LabCorp Clinical Trials's NAICS code?

Minus sign iconPlus sign icon
LabCorp Clinical Trials's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does LabCorp Clinical Trials have currently?

Minus sign iconPlus sign icon
As of July 2026, LabCorp Clinical Trials has approximately 273 employees across 6 continents, including North AmericaEuropeAsia. Key team members include Flow Cytometry Manager Europe/Asia: M. L.Associate Manager - Medical Coding: R. N. C.Study Design Lead: J. W.. Explore LabCorp Clinical Trials's employee directory with LeadIQ.

What industry does LabCorp Clinical Trials belong to?

Minus sign iconPlus sign icon
LabCorp Clinical Trials operates in the Pharmaceutical Manufacturing industry.

What technology does LabCorp Clinical Trials use?

Minus sign iconPlus sign icon
LabCorp Clinical Trials's tech stack includes Micro Focus Application Lifecycle ManagementAdobeSaba LMSThe Prosci ADKAR ModelSAP Plant MaintenanceOpenAI CodexOracle EloquaFedEx.

What is LabCorp Clinical Trials's email format?

Minus sign iconPlus sign icon
LabCorp Clinical Trials's email format typically follows the pattern of First.Last@labcorp.com. Find more LabCorp Clinical Trials email formats with LeadIQ.
LabCorp Clinical Trials logo

LabCorp Clinical Trials

Pharmaceutical Manufacturing201-500 Employees

LabCorp Clinical Trials operates in the pharmaceutical manufacturing industry and employs between 201 and 500 people; its website is labcorp.com. It forms part of Labcorp and Covance, providing end-to-end drug development support through Covance Drug Development and clinical laboratory services through LabCorp Diagnostics, with plans to operate together under the Covance brand. The company serves a range of healthcare stakeholders, including physicians, patients and consumers, biopharmaceutical companies, government agencies, managed care organizations, hospitals, and clinical labs. Recent activities include the June 2026 launch of ColoSense, an FDA-approved RNA-based at-home colorectal cancer screening test, and the May 2026 introduction of MyLabcorp, an AI-powered mobile app to help consumers understand lab results and track health trends. In 2019 LabCorp disclosed a cybersecurity incident involving unauthorized access to protected health information, and in June 2026 it agreed to pay $35 million to settle an AMCA data breach.

Section iconCompany Overview

NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Employees
201-500

Section iconFunding & Financials

  • $250M$500M

    LabCorp Clinical Trials's revenue is estimated to be in the range of $250M$500M

Section iconFunding & Financials

  • $250M$500M

    LabCorp Clinical Trials's revenue is estimated to be in the range of $250M$500M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.